JAZZ PHARMACEUTICALS INC

Profile

Company Names

JAZZ PHARMACEUTICALS INC

Addresses

3180 PORTER DRIVE, PALO ALTO, CA 94304

Phone Numbers

650-496-3777

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$206,999,998.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2009-07-07 
$6,999,998.00 
$6,999,998.00 
$0.00 
Equity 
3
2008-05-07 
$0.00 
$2,024,000.00 
$2,024,000.00 
 
2
2008-03-14 
$120,000,000.00 
$125,250,873.00 
$5,250,873.00 
Debt 
1
2005-06-24 
$80,000,000.00 
$87,338,700.00 
$7,338,700.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
E. 
ALEXANDER 
ALBERT 
DIRECTOR
JAZZ PHARMACEUTICALS INC
SAMUEL 
D. 
COLELLA 
DIRECTOR
JAZZ PHARMACEUTICALS INC   |  VERACYTE, INC.   |  FLUIDIGM CORP   |  VERSANT AFFILIATES FUND I-B LP   |  VERSANT AFFILIATES FUND I-A LP   |  VERSANT SIDE FUND I LP   |  ALEXZA PHARMACEUTICALS INC.   |  VERSANT SIDE FUND II, LP
JOAN 
E. 
COLLIGAN 
EXECUTIVE OFFICER
JAZZ PHARMACEUTICALS INC
BRUCE 
C. 
COZADD 
EXECUTIVE OFFICER, DIRECTOR
THRESHOLD PHARMACEUTICALS INC   |  JAZZ PHARMACEUTICALS INC
BRUCE 
 
COZZAD 
EXECUTIVE OFFICER, DIRECTOR
JAZZ PHARMACEUTICALS INC
BRIAN 
C. 
CRESSEY 
DIRECTOR
JAZZ PHARMACEUTICALS INC
BRYAN 
C. 
CRESSEY 
DIRECTOR
JAZZ PHARMACEUTICALS INC   |  CRESSEY + CO FUND IV LP   |  U S RENAL CARE INC   |  CRESSEY + CO FUND VII LP   |  CRESSEY + CO FUND VII-A LP
PATRICK 
G. 
ENRIGHT 
DIRECTOR
JAZZ PHARMACEUTICALS INC   |  CORCEPT THERAPEUTICS INC   |  ESPERION THERAPEUTICS, INC.   |  CARDIODX INC   |  APTINYX INC.   |  AIMMUNE THERAPEUTICS, INC.   |  ENDEAVOR BIOMEDICINES, INC.
CAROL 
A. 
GAMBLE 
EXECUTIVE OFFICER
JAZZ PHARMACEUTICALS INC
MICHAEL 
W. 
MICHAELSON 
DIRECTOR
JAZZ PHARMACEUTICALS INC   |  KKR ASIAN FUND II ESC L.P.   |  KKR ASIAN FUND II SBS L.P.
MICHAEL 
W. 
MICHELSON 
DIRECTOR
JAZZ PHARMACEUTICALS INC   |  HUPAH MANAGEMENT, L.P.   |  KKR NORTH AMERICA FUND XI PRIVATE INVESTORS L.P.   |  KKR NORTH AMERICA FUND XI L.P.   |  KKR ASIAN FUND II PRIVATE INVESTORS L.P.   |  KKR ASIAN FUND II L.P.   |  KKR NORTH AMERICA FUND XI ESC L.P.   |  KKR NORTH AMERICA FUND XI SBS L.P.   |  KPOP GS FEEDER (OFFSHORE) L.P.   |  KPOP GS FEEDER (DOMESTIC) L.P.   |  KKR PRINCIPAL OPPORTUNITIES PARTNERSHIP (OFFSHORE) L.P.   |  KKR PRINCIPAL OPPORTUNITIES PARTNERSHIP (DOMESTIC) L.P.   |  ZIMMER BIOMET HOLDINGS, INC.
JAMES 
C. 
MOMTAZEE 
DIRECTOR
JAZZ PHARMACEUTICALS INC   |  ENTELLUS MEDICAL INC   |  COVENANT SURGICAL HOLDINGS CORP
ROBERT 
M. 
MYERS 
EXECUTIVE OFFICER, DIRECTOR
JAZZ PHARMACEUTICALS INC   |  ORBUS THERAPEUTICS, INC.
KENNETH 
W. 
O-KEEFE 
DIRECTOR
JAZZ PHARMACEUTICALS INC   |  BEECKEN PETTY O-KEEFE FUND IV, L.P.   |  BEECKEN PETTY O-KEEFE FUND IV-A, L.P.   |  BEECKEN PETTY O-KEEFE FUND V, L.P.   |  BEECKEN PETTY O-KEEFE FUND V-A, L.P.
ALAN 
M. 
SEBULSKY 
DIRECTOR
LIFESYNC HOLDINGS INC   |  JAZZ PHARMACEUTICALS INC
JAMES 
B. 
TANANBAUM 
DIRECTOR
JAZZ PHARMACEUTICALS INC   |  PATHWORK DIAGNOSTICS INC   |  FORESITE CAPITAL II-AA, LLC   |  FORESITE CAPITAL IV-C, LLC   |  FORESITE CAPITAL FUND II, L.P.   |  PARDES BIOSCIENCES, INC   |  ALUMIS INC.
JANNE 
L.T. 
WISSEL 
EXECUTIVE OFFICER
JAZZ PHARMACEUTICALS INC
NATHANIEL 
M. 
ZILKHA 
DIRECTOR
JAZZ PHARMACEUTICALS INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2009-11-27
D/A
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2005-06-24 
2009-11-27
D/A
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2008-05-07 
2009-11-25
D/A
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2008-03-14 
2009-07-08
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2009-07-07 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#